B. Dobosz

Transforming growth factor-Beta 1 (tgf-Beta 1) in patients with amyotrophic lateral sclerosis.

Z. Stelmasiak, J. Iłżecka, B. Dobosz, 2002, Cytokine.

Interleukin‐8 and RANTES levels in patients with relapsing–remitting multiple sclerosis (RR‐MS) treated with cladribine

Z. Stelmasiak, H. Bartosik-Psujek, K. Mitosek-Szewczyk, 2004, Acta neurologica Scandinavica.

Decreased level of kynurenic acid in cerebrospinal fluid of relapsing-onset multiple sclerosis patients

G. Giovannoni, W. Turski, K. Rejdak, 2002, Neuroscience Letters.

Interleukin‐1β converting enzyme/Caspase‐1 (ICE/Caspase‐1) and soluble APO‐1/Fas/CD 95 receptor in amyotrophic lateral sclerosis patients

Z. Stelmasiak, J. Iłżecka, B. Dobosz, 2001 .

Interleukin-1beta converting enzyme/Caspase-1 (ICE/Caspase-1) and soluble APO-1/Fas/CD 95 receptor in amyotrophic lateral sclerosis patients.

Z. Stelmasiak, J. Iłżecka, B. Dobosz, 2001, Acta neurologica Scandinavica.

Interleukin-6 concentration in serum and cerebrospinal fluid in multiple sclerosis patients.

K. Rejdak, Z. Stelmasiak, H. Bartosik-Psujek, 2000, Medical science monitor : international medical journal of experimental and clinical research.

IL-6 and sIL-6R concentration in the cerebrospinal fluid and serum of MS patients.

K. Rejdak, Z. Stelmasiak, M. Kozioł-Montewka, 2001, Medical science monitor : international medical journal of experimental and clinical research.